Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 9, 2004, Pages 991-996

  Akizuki, Setsuko ^a   Ohnishi, Akihiro ^a   Kotani, Kazuo ^b   Sudo, Kayoko ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAIICHI PURE CHEMICALS CO LTD   (Japan)

^c Saitama Junior College   (Japan)

Author keywords

Butyrylcholinesterase; C5 variant; Enzyme linked immunosorbent assay

Indexed keywords

ALBUMIN ANTIBODY; CHOLINESTERASE; ENZYME VARIANT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; RNA;

ADULT; AGED; ARTICLE; CALCULATION; CASE REPORT; CHOLINESTERASE BLOOD LEVEL; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; HUMAN; IMMUNOLOGICAL PROCEDURES; MALE; PHENOTYPE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN CONTENT; RNA TRANSLATION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BUTYRYLCHOLINESTERASE; CHOLINESTERASES; COMPLEMENT C5; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; VARIATION (GENETICS);

EID: 4744361649     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.201     Document Type: Article

References (38)

1. Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625-34.
2. Prody CA, Zevin-Sonkin D, Gnatt A, Goldberg O, Soreq H. Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues. Proc Natl Acad Sci USA 1987;84:3555-9.
3. Vellom DC, Radic Z, Li Y, Pickering NA, Camp S, Taylor P. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase. Biochemistry 1993;32:12-17.
4. Lockridge O. Genetic variants of human serum cholinesterase Influence metabolism of the muscle relaxant succinylcholine. Pharmac Ther 1990;47:35-60.
5. Masson P. A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. Biochim Biophys 1989;988:258-66.
6. Harris H, Hopkinson DA, Robson EB, Whittaker M. Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann Hum Genet (Lond) 1963;26:359-82.
7. Steegmüller H. On the geographical distribution of pseudocholinesterase variants. Humangenetik 1975;26: 167-85.
8. Marazita ML, Keats BJ, Spence MA, Sparkes RS, Field LL, Sparkes MC, et al. Mapping studies of the serum cholinesterase-2 locus(CHE2). Hum Genet 1989;83:139-44.
9. Kidd KK, Gusella J. Report of the committee on the genetic constitution of chromosomes 3 and 4. J Cytogenet Cell Genet 1985;40:107-27.
10. Yang F, Lim JB, McGill JR, Moore CM, Naylor SL, Van Bragt PH, et al. Human transferrin: cDNA characterization and chromosomal localization. Proc Natl Acad Sci USA 1984;81:2752-6.
11. Maekawa M, Sudo K, Kanno T, Kotani K, Dey DC, Ishikawa J, et al. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes. Clin Chim Acta 1995;235:41-57.
12. Sudo K, Maekawa M, Kanno T, Akizuki S, Magara T. Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles. Clin Biochem 1996;29:165-9.
13. Maekawa M, Sudo K, Dey DC, Ishikawa J, Izumi M, Kotani K, et al. Genetic mutations of butyrylcholine esterase Identified from phenotypic abnormalities in Japan. Clin Chem 1997;43:924-9.
14. La Du BN, Bartels CF, Nogueira CP, Arpagaus M, Lockridge O. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol 1991;11:79-89.
15. Eiberg H, Nielsen LS, Klausen J, Dahlen M, Kristensen M, Bisgaard ML, et al. Linkage between serum cholinesterase2(CHE2)and γ-crystalline gene cluster (CRYG):assignment to chromosome2. Clin Genet 1989;35:313-21.
16. Chautard-Freire-Maia EA, Primo-Parmo SL, Picheth G, Lourenco MAC. The C5 isozyme of serum cholinesterase and adult weight. Hum Hered 1991;41:330-9.
17. Iuchi I. Abnormal pseudocholinesterase. Jpn J Human Genet 1982;27:95-101.
18. Yoshida A, Motulsky AG. A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity. Am J Hum Genet 1969;21:486-98.
19. Harris H, Robson EB, Len-Bott AMG, Thornton JA. Evidence for non-allelism between genes affecting human serum cholinesterase. Nature 1963;200:1185-7.
20. Harris H, Hopkinson DA, Robson EB, Whittaker M. Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann Hum Genet (Lond) 1963;26:359-82.
21. Neitlich HW. Increased plasma cholinesterase activity and succinyl-choline resistance: a genetic variant. J Clin Invest 1966;45:380-7.
22. Arpagaus M, Kott M, Vatsis KP, Bartels CF, La Du BN, Lockridge O. Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry 1990;29:124-31.
23. Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE. Complete amino acid sequence of human serum cholinesterase. J Biol Chem 1987;262:549-57.
24. Masson P, Chatonnet A, Lockridge O. Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant(CHE2). FEBS 1990;262:115-8.
25. Sugimori T. Shortened action of succinylcholine in individuals with cholinesterase C5 Isozyme. Can Anaesth Soc J 1986;33:321-7.
26. Maekawa M, Sudo K, Kanno T. A simple staining method to detect serum cholinesterase activity. Clin Chim Acta 1987;164:241-2.
27. Kotani K, Maekawa M, Hara K, Kanno T. Clinical significance of serum cholinesterase concentrations determined by enzyme-linked immunosorbent assay (ELISA). Jpn J Clin Pathol 1996;44:965-9.
28. Itoh Y, Fukamachi I, Hashimoto H, Hachisu T, Kawai T. Enzyme-linked immunosorbent assay for serum pseudocholinesterase. Clin Chim Acta 1992;207:11-8.
29. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977;74:1245-9.
30. McGuire MC, Nogueira CP, Bartels CF, Lightstone H, Hajra H, Van der Spek AFL, et al. Identification of the structural mutation responsible for the dibuaine-resistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci USA 1989;86:953-7.
31. Nagai K, Sakata S, Kametani M, Gomi K, Tokimitsu N, Miura K. Familiar hypercholinesterasemia. A case report. Jpn J Med 1986;25:313-6.
32. Scott EM, Powers RF. Properties of the C5 variant form of human serum cholinesterase. Am J Hum Genet 1974;26:189-94.
33. Masson P. Molecular heterogeneity of human plasma cholinesterase. American Chemical Society. 3rd International Meeting on Cholinesterase, 1990: 42-7.
34. Ohkawa J, Furuya I, Tabata S, Saeki S, Oimomi T, Baba S. Chemical characterization of C5 cholinesterase isozyme. Chem Enzyme 1988;40(Suppl 1):37-8.
35. Rubinstein HM, Dietz AA, Lubrano T. E1k, another quantitative variant at cholinesterase locus 1. J Med Genet 1978;15:27-9.
36. Bartels CF, Jensen FS, Lockridge O, van der Spek AFL, Rubinstein HM, Lubrano T, et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50:1086-103.
37. Izumi M, Maekawa M, Kanno T. Butyrylcholinesterase K-variant in Japan: frequency of allele and associated enzyme activity in serum. Clin Chem 1994;40:1606-7.
38. Altamirano CV, Bartels CF, Lockridge O. The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme. J Neurochem 2000;74:869-77.